Parkinsonian Disorders: all 218 studies
Page 3 of 3. Open to participants first (63), then studies with results posted, then the rest; newest registration first within each.
- Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.Status unknownNCT00355927Not applicable
- The Study of the Impact of Disclosing Imaging Study Information to Trial ParticipantsCompletedNCT00354003
- Development of Imaging, Clinical and Biochemical Bio-Markers for Parkinson's DiseaseCompletedNCT00315250Phase 2
- Imaging and Genetic Biomarkers of Parkinson Disease (PD) Onset and Progression in High-risk FamiliesCompletedNCT00273351Phase 2
- Clinical, Molecular and Metabolic Characteristics of Parkinson's Disease (PD) Patients With Parkin MutationStatus unknownNCT00169364Not applicable
- Biomechanical Parameters of Gait in Patients With Parkinson's Disease and Parkinsonian SyndromesTerminatedNCT00139321Not applicable
- Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian SyndromeCompletedNCT00132626Phase 2
- Study of Individuals With Parkinson's Symptoms But in Whom There is Diagnostic UncertaintyCompletedNCT00129675Phase 2
- Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's DiseaseCompletedNCT00129181Not applicable
- A Study of Brain Imaging With Nuclear Medicine Technology in Individuals With and at Risk for Parkinson's DiseaseCompletedNCT00117819Phase 2
- A Study of Neurophysiologic Changes in Individuals With Parkinson's DiseaseCompletedNCT00117195
- Consortium On Risk for Early-onset Parkinson's Disease (CORE PD)CompletedNCT00104585
- A Study of the Sense of Smell in Relatives of Parkinson's Disease PatientsCompletedNCT00096876
- Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's DiseaseCompletedNCT00096720Phase 2
- Biological Markers in Parkinson's DiseaseCompletedNCT00088335
- Continuously Infused Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (GDNF) to Treat Progressive Supranuclear PalsyCompletedNCT00005903Phase 2
- Intravenous Levodopa for the Diagnosis of Parkinson's DiseaseCompletedNCT00001928
- Diagnosis and Natural History Study of Patients With Neurological ConditionsCompletedNCT00001549